Skip to main content

Table 2 Predictive factors for tumor response and risk factors associated with ILD (univariate analysis)

From: Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

Factor

Response

proportion (%)

Odds

ratio (95% CI)

p-value

Incidence of

ILD (%)

Odds ratio

(95% CI)

p-value

Age

-

1.01 (0.98–1.03)

0.644

 

1.00 (0.95–1.04)

0.823

Sex

      

   Male

8.4

1

-

2.7

1

-

   Female

34.3

5.68 (3.33–9.69)

<0.001

4.2

1.60 (0.61–4.21)

0.344

Histological type

      

   Non-adenocarcinoma

6.0

1

-

3.6

1

-

   Adenocarcinoma

23.6

4.86 (2.27–10.42)

<0.001

3.1

0.84 (0.31–2.33)

0.737

History of smoking

      

   Yes

10.5

1

-

3.1

1

-

   No

33.8

4.33 (2.57–7.29)

<0.001

4.1

1.33 (0.50–3.57)

0.573

ECOG performance status

      

   2–4

14.4

1

-

2.6

1

-

   0–1

20.3

1.51 (0.89–2.59)

0.129

3.6

1.39 (0.48–4.00)

0.549

Concurrent interstitial pneumonitis

      

   No

18.9

1

-

3.2

1

 

   Yes

5.0

0.23 (0.03–1.72)

0.151

3.8

1.21 (0.15–9.49)

 

Concurrent pulmonary emphysema

      

   No

19.9

1

-

3.1

1

 

   Yes

7.1

0.31 (0.11–0.88)

0.028

3.9

1.25 (0.35–4.47)

 

Prior surgery

      

   No

16.0

1

-

3.6

1

-

   Yes

22.2

1.49 (0.91–2.44)

0.111

2.6

0.74 (0.26 -2.12)

0.571

Prior chemotherapy

      

   No

28.6

1

-

2.6

1

-

   Yes

15.5

0.46 (0.27–0.79)

0.005

3.4

1.32 (0.37–4.66)

0.670

Prior thoracic radiotherapy

      

   No

19.3

1

-

3.9

1

-

   Yes

16.6

0.83 (0.50–1.38)

0.468

2.1

0.51 (0.17–1.60)

0.250

Concurrent chemotherapy with

agent other than gefitinib

      

   No

17.3

1

-

3.5

-

-

   Yes

28.6

1.91 (0.88–4.15)

0.103

0

-

-

Thoracic radiotherapy concurrent

with or after gefitinib treatment

      

   No

18.8

1

-

3.1

1

-

   Yes

12.8

0.64 (0.24–1.69)

0.364

4.2

1.34 (0.30–6.05)

0.702

Absolute neutrophil count *

-

0.84 (0.75–0.95)

0.004

-

0.96 (0.81–1.14)

0.609

Aspartate aminotransferase level **

-

1.00 (0.99–1.01)

0.967

-

0.99 (0.95–1.03)

0.635

Lactate dehydrogenase level ***

-

0.82 (0.65–1.03)

0.085

-

0.95 (0.71–1.27)

0.724

Albumin level ****

-

1.54 (0.97–2.44)

0.067

-

1.65 (0.67–4.07)

0.278

  1. * per: 1000/μL **: per IU/L ***: per 100 IU/L ****: per g/dL